Cost Effectiveness of Treatment Options in Advanced Breast Cancer in the UK.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 11, p. 1091, doi. 10.2165/00019053-200119110-00003
- By:
- Publication type:
- Article
Works matching IS 11707690 AND DT 2001 AND VI 19 AND IP 11
Results: 6
1
2
Economic Evaluations During Early (Phase II) Drug Development: A Role for Clinical Trial Simulations?
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 11, p. 1069, doi. 10.2165/00019053-200119110-00001
- By:
- Publication type:
- Article
3
Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996).
- Published in:
- 2001
- By:
- Publication type:
- journal article
4
Paclitaxel: a pharmacoeconomic review of its use in non-small cell lung cancer.
- Published in:
- 2001
- By:
- Publication type:
- journal article
5
Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
- Published in:
- 2001
- By:
- Publication type:
- journal article
6
Quality-of-life assessment in patients with benign prostatic hyperplasia: effects of various interventions.
- Published in:
- 2001
- By:
- Publication type:
- journal article